Dr. Ash Pirouz, MD

Dr. Pirouz practices at Fullerton Clinical and Surgical Facility in Fullerton, California.

Dr. Pirouz's NPI, 1942489356, was assigned on November 1, 2007. Dr. Pirouz graduated from The Johns Hopkins University School of Medicine in 2005. Dr. Pirouz holds California license A97183.

Dr. Pirouz's primary practice is Fullerton Clinical and Surgical Facility, at 301 W Bastanchury Rd, Fullerton, CA 92835 in Orange County. The practice phone is (949) 706-2887.

Dr. Pirouz's primary practice is Fullerton Clinical and Surgical Facility in Fullerton, California. Dr. Pirouz is also affiliated with Providence St. Jude Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Pirouz to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pirouz practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Pirouz's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Pirouz is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Pirouz is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hereditary corneal conditions, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Pirouz treats.

CMS data shows 84,309 Medicare services from Dr. Pirouz across 19 procedure codes in 2024, for 912 Medicare patients. Medicare paid $3,649,263 for them.

CMS counts 912 Medicare patients who saw Dr. Pirouz in 2024. The largest group is 75 to 84, with 365 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pirouz's median patient age at 74, with 56% women.

In 2024, Dr. Pirouz wrote 756 Medicare Part D claims for 188 patients. 64% of them were for generic drugs. CMS names the drug for 675 of them, across 11 drugs with 11 or more claims each, at $33,512 in total drug cost. In 2023, CMS named 564 claims across 12 drugs.

Dr. Pirouz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Pirouz, published from 2017 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Angiogenesis Inhibitors, Choroidal Neovascularization and Intravitreal Injections. Dr. Pirouz's most frequent co-authors are Sean David Adrean, MD, Scott Grant, MD and Siyang Chaili, MD.

Dmand AI links Dr. Pirouz to 2 clinical trials. Conditions studied include Macular Degeneration and Retinal Degeneration. Open Payments lists research payments to Dr. Pirouz that name 2 trials.

CMS Open Payments shows 265 general payments to Dr. Pirouz from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 47% of the total. Allergan Inc. paid the most, $11,663. It also lists 38 research payments totaling $188,445 from 2016 to 2018, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Pirouz, most recently CMS Stage 1 EHR in 2013.

Dr. Pirouz graduated from The Johns Hopkins University School of Medicine in 2005.

Dr. Pirouz is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.